BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story. Viruses 2021;13:277. [PMID: 33670195 DOI: 10.3390/v13020277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Charoensappakit A, Sae-Khow K, Leelahavanichkul A. Gut Barrier Damage and Gut Translocation of Pathogen Molecules in Lupus, an Impact of Innate Immunity (Macrophages and Neutrophils) in Autoimmune Disease. Int J Mol Sci 2022;23:8223. [PMID: 35897790 DOI: 10.3390/ijms23158223] [Reference Citation Analysis]
2 Barcellini W, Colombatti R. The impact of Parvovirus B19 on hereditary haemolytic anaemias. Br J Haematol 2021;193:703-4. [PMID: 33929757 DOI: 10.1111/bjh.17485] [Reference Citation Analysis]
3 Buonavoglia A, Leone P, Prete M, Solimando AG, Guastadisegno C, Lanave G, Camero M, Martella V, Lo Muzio L, Racanelli V. Epstein-Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions. J Clin Med 2021;10:4995. [PMID: 34768514 DOI: 10.3390/jcm10214995] [Reference Citation Analysis]
4 Enfrein A, Hamidou M. Epstein-Barr Virus et lupus systémique : quels liens ? La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.03.341] [Reference Citation Analysis]
5 Su R, Yan H, Li N, Ding T, Li B, Xie Y, Gao C, Li X, Wang C. Application value of blood metagenomic next-generation sequencing in patients with connective tissue diseases. Front Immunol 2022;13:939057. [DOI: 10.3389/fimmu.2022.939057] [Reference Citation Analysis]
6 Nossent J, Keen H, Preen DB, Inderjeeth CA. Temporal trends in hospitalisation for opportunistic infections in lupus patients in Western Australia. Lupus 2022;:9612033221115965. [PMID: 35839098 DOI: 10.1177/09612033221115965] [Reference Citation Analysis]
7 Ramaswamy M, Tummala R, Streicher K, Nogueira da Costa A, Brohawn PZ. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases. Int J Mol Sci 2021;22:11286. [PMID: 34681945 DOI: 10.3390/ijms222011286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
8 Krasselt M, Kippenhahn A, Baerwald C, Pietsch C, Seifert O. Relationship between cytomegalovirus prevalence and markers of disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2021:keab811. [PMID: 34718424 DOI: 10.1093/rheumatology/keab811] [Reference Citation Analysis]
9 Hernández-Doño S, Jakez-Ocampo J, Márquez-García JE, Ruiz D, Acuña-Alonzo V, Lima G, Llorente L, Tovar-Méndez VH, García-Silva R, Granados J, Zúñiga J, Vargas-Alarcón G. Heterogeneity of Genetic Admixture Determines SLE Susceptibility in Mexican. Front Genet 2021;12:701373. [PMID: 34413879 DOI: 10.3389/fgene.2021.701373] [Reference Citation Analysis]